A. Castellarin

发表

Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration.

R. Avery, D. Pieramici, M. Rabena, 2006, Ophthalmology.

SYSTEMIC PHARMACOKINETICS AND PHARMACODYNAMICS OF INTRAVITREAL AFLIBERCEPT, BEVACIZUMAB, AND RANIBIZUMAB

R. Avery, D. Pieramici, M. Rabena, 2017, Retina.

Retinal imaging with adaptive optics scanning laser ophthalmoscopy in unexplained central ring scotoma.

Steven M. Jones, Diana C. Chen, S. Sadda, 2008, Archives of ophthalmology.

Clinicopathological correlation of primary and recurrent choroidal neovascularisation following surgical excision in age related macular degeneration

M. Zarbin, A. Castellarin, M. Nasir, 1998, The British journal of ophthalmology.

TREATMENT OF VITREOMACULAR TRACTION WITH INTRAVITREAL PERFLUOROPROPANE (C3F8) INJECTION

R. Avery, D. Pieramici, A. Castellarin, 2017, Retina.

OUTER RETINA REFLECTIVITY CHANGES ON SD-OCT AFTER INTRAVITREAL OCRIPLASMIN FOR VITREOMACULAR TRACTION AND MACULAR HOLE

R. Avery, D. Pieramici, M. Rabena, 2015, Retina.

Endophthalmitis after anti-VEGF injections.

M. K. Walsh, D. Roth, L. Halperin, 2009, Ophthalmology.

Clinicopathological correlation of an excised choroidal neovascular membrane in pseudotumour cerebri

M. Zarbin, A. Castellarin, M. Nasir, 1997, The British journal of ophthalmology.

Intravitreal bevacizumab. Authors' reply

R. Avery, D. Pieramici, M. Rabena, 2007 .

Progressive presumed choriocapillaris atrophy after surgery for age-related macular degeneration.

M. Zarbin, A. Castellarin, M. Nasir, 1998, Retina.

Case of anterior uveitis after intravitreal injection of bevacizumab.

R. Avery, D. Pieramici, M. Rabena, 2006, Retina.

INTRAVITREAL BEVACIZUMAB (AVASTIN) IN THE TREATMENT OF MACULAR EDEMA SECONDARY TO BRANCH RETINAL VEIN OCCLUSION

R. Avery, D. Pieramici, A. Castellarin, 2007, Retina.

Anterior segment complications following periocular and intraocular injections.

D. Pieramici, A. Castellarin, 2004, Ophthalmology clinics of North America.

Systemic pharmacokinetics following intravitreal injections of ranibizumab, bevacizumab or aflibercept in patients with neovascular AMD

R. Avery, D. Pieramici, M. Rabena, 2014, British Journal of Ophthalmology.

Ultrastructural analysis of hydraulic and abrasive retinal pigment epithelial cell debridements.

M. Zarbin, A. Castellarin, I. Sugino, 2003, Experimental eye research.

Intravitreal bevacizumab (Avastin) in the treatment of proliferative diabetic retinopathy.

R. Avery, J. Pearlman, D. Pieramici, 2006, Ophthalmology.

In vitro transplantation of fetal human retinal pigment epithelial cells onto human cadaver Bruch's membrane.

M. Zarbin, G. Lui, A. Castellarin, 1998, Experimental eye research.

Early attachment of uncultured retinal pigment epithelium from aged donors onto Bruch's membrane explants.

M. Zarbin, A. Castellarin, I. Sugino, 2002, Experimental eye research.

Short-term study of allogeneic retinal pigment epithelium transplants onto debrided Bruch's membrane.

M. Zarbin, A. Castellarin, H. Wang, 2001, Investigative ophthalmology & visual science.

Change in Diabetic Retinopathy Through 2 Years: Secondary Analysis of a Randomized Clinical Trial Comparing Aflibercept, Bevacizumab, and Ranibizumab

P. Kaufman, S. Bressler, L. Jampol, 2017, JAMA ophthalmology.

[Catch-up growth and final height in celiac disease].

A. Luciano, M. Bolognani, A. Castellarin, 2002, La Pediatria Medica e Chirurgica.

Incidence of choroidal neovascularization in the fellow eye in the comparison of age-related macular degeneration treatments trials.

R. Avery, Jiayan Huang, D. Roth, 2013, Ophthalmology.

Efficacy, durability, and safety of intravitreal faricimab with extended dosing up to every 16 weeks in patients with diabetic macular oedema (YOSEMITE and RHINE): two randomised, double-masked, phase 3 trials.

Arthur D. Fu, Ajay E. Kuriyan, Rishi P. Singh, 2022, Lancet.

INTRAVITREAL RANIBIZUMAB FOR MACULAR EDEMA SECONDARY TO CENTRAL RETINAL VEIN OCCLUSION

R. Avery, D. Pieramici, M. Rabena, 2011, Retina.

Ranibizumab for the treatment of macular edema associated with perfused central retinal vein occlusions.

R. Avery, D. Pieramici, M. Rabena, 2007, Ophthalmology.

Repositioning of glaucoma tubes into the pars plana for refractory malignant glaucoma: a case report

Michael Song, A. Castellarin, Julia Song, 2013, Journal of Medical Case Reports.

Comparison of Three Non-surgical Treatments for Vitreomacular Traction (VMT)

R. Avery, D. Pieramici, A. Castellarin, 2016 .

Intravitreal Bevacizumab (Avastin®) for Retinal Vein Occlusion

R. Avery, D. Pieramici, M. Rabena, 2006 .

Residual edema evaluation with ranibizumab 0.5 mg and 2.0 mg formulations for diabetic macular edema (REEF study)

R. Avery, D. Pieramici, M. Rabena, 2015, Eye.

Intravitreal Perfluoropropane Gas (C3F8) Versus Ocriplasmin for Vitreomacular Traction (VMT)

R. Avery, Carlos Quezada, D. Pieramici, 2015 .

LARGE SILICONE DROPLETS AFTER INTRAVITREAL BEVACIZUMAB (AVASTIN)

R. Avery, D. Pieramici, A. Castellarin, 2017, Retinal cases & brief reports.

Efficacy, durability, and safety of faricimab with extended dosing up to every 16 weeks in Japanese patients with diabetic macular edema: 1-year results from the Japan subgroup of the phase 3 YOSEMITE trial

R. Shah, P. Campochiaro, S. Gupta, 2023, Japanese Journal of Ophthalmology.

Vitrectomy with silicone oil infusion in severe diabetic retinopathy

N. Bhagat, L. D. Del Priore, R. Grigorian, 2003, The British journal of ophthalmology.